Olema Pharmaceuticals, Inc. (OLMA)
14.08
-0.88
(-5.88%)
USD |
NASDAQ |
Mar 20, 16:00
14.10
+0.02
(+0.14%)
After-Hours: 20:00
Olema Pharmaceuticals Research and Development Expense (Quarterly) : 43.22M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 74.38M |
| EyePoint Plc | 59.21M |
| CytomX Therapeutics, Inc. | 20.76M |
| Corvus Pharmaceuticals, Inc. | 9.939M |
| Protagonist Therapeutics, Inc. | 46.36M |